Should Steroid Therapy Be Necessarily Needed for Autoimmune Pancreatitis Patients with Lesion Resected due to Misdiagnosed or Suspected Malignancy?

الملخص EN

To explore whether steroid therapy should be needed for autoimmune pancreatitis patients after operation, eight AIP patients receiving operation were enrolled in this study from January 2007 to July 2013.

All patients underwent liver function, CA19-9, and contrast-enhanced CT and/or MRI.

Tests of IgG and IgG4 were performed in some patients.

Tests of serum TB/DB, γ-GT, and γ-globulin were undergone during the perioperative period.

Six cases receiving resection were pathologically confirmed as AIP patients and two were confirmed by intraoperative biopsy.

For seven patients, TB/DB level was transiently elevated 1 day or 4 days after operation but dropped below preoperative levels or to normal levels 7 days after operation, and serum γ-GT level presented a downward trend.

Serum γ-globulin level exhibited a downward trend among six AIP patients after resection, while an upward trend was found in another two AIP patients receiving internal drainage.

Steroid therapy was not given to all six AIP patients until two of them showed new lines of evidence of residual or extrapancreatic AIP lesion after operation, while another two cases without resection received steroid medication.

Steroid therapy might not be recommended unless there are new lines of evidence of residual extrapancreatic AIP lesions after resection.